Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice

被引:0
|
作者
Pan, Ruangang [1 ]
Li, Pengfei [1 ]
Meyerholz, David K. [2 ]
Perlman, Stanley [1 ,3 ]
机构
[1] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Pathol, Iowa City, IA USA
[3] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; mouse adapted coronavirus; nsp4; nsp8; innate immune response;
D O I
10.1128/jvi.00584-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has resulted in substantial morbidity and mortality. The basis of severe disease in humans is difficult to determine without the use of experimental animal models. Mice are resistant to infection with ancestral strains of SARS-CoV-2, although many variants that arose later in the pandemic were able to directly infect mice. In almost all cases, viruses that naturally infected mice or were engineered to enable mouse infection required mouse passage to become virulent. In most cases, changes in structural and nonstructural changes occurred during mouse adaptation. However, the mechanism of increased virulence in mice is not understood. Here, using a recently described strain of mouse-adapted SARS-CoV-2 (rSARS2-MA30N501Y), we engineered a series of recombinant viruses that expressed a subset of the mutations present in rSARS2-MA30N501Y. Mutations were detected in the spike protein and in three nonstructural proteins (nsp4, nsp8, and nsp9). We found that infection of mice with recombinant SARS-CoV-2 expressing only the S protein mutations caused very mild infection. Addition of the mutations in nsp4 and nsp8 was required for complete virulence. Of note, all these recombinant viruses replicated equivalently in cultured cells. The innate immune response was delayed after infection with virulent compared to attenuated viruses. Further, using a lineage tracking system, we found that attenuated virus was highly inhibited in the ability to infect the parenchyma, but not the airway after infection. Together, these results indicate that mutations in both the S protein and nonstructural proteins are required for maximal virulence during mouse adaptation. IMPORTANCE Understanding the pathogenesis of coronavirus disease 2019 (COVID-19) requires the study of experimental animals after infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). For this purpose, several mouse-adapted SARS-CoV-2 strains have been developed. Here, using a strain of mouse-adapted virus that causes a range of diseases ranging from mild to severe, we show that mutations in both a structural protein [spike (S) protein] and nonstructural proteins are required for maximal virulence. Thus, changes in the S protein, the most widely studied viral protein, while required for mouse adaptation, are not sufficient to result in a virulent virus. Understanding the pathogenesis of coronavirus disease 2019 (COVID-19) requires the study of experimental animals after infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). For this purpose, several mouse-adapted SARS-CoV-2 strains have been developed. Here, using a strain of mouse-adapted virus that causes a range of diseases ranging from mild to severe, we show that mutations in both a structural protein [spike (S) protein] and nonstructural proteins are required for maximal virulence. Thus, changes in the S protein, the most widely studied viral protein, while required for mouse adaptation, are not sufficient to result in a virulent virus.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
    Aid, Malika
    Busman-Sahay, Kathleen
    Vidal, Samuel J.
    Maliga, Zoltan
    Bondoc, Stephen
    Starke, Carly
    Terry, Margaret
    Jacobson, Connor A.
    Wrijil, Linda
    Ducat, Sarah
    Brook, Olga R.
    Miller, Andrew D.
    Porto, Maciel
    Pellegrini, Kathryn L.
    Pino, Maria
    Hoang, Timothy N.
    Chandrashekar, Abishek
    Patel, Shivani
    Stephenson, Kathryn
    Bosinger, Steven E.
    Andersen, Hanne
    Lewis, Mark G.
    Hecht, Jonathan L.
    Sorger, Peter K.
    Martinot, Amanda J.
    Estes, Jacob D.
    Barouch, Dan H.
    CELL, 2020, 183 (05) : 1354 - +
  • [22] ZBP1 inflames the SARS-CoV-2-infected lung
    Chaoran Yin
    Siddharth Balachandran
    Cell Research, 2023, 33 : 333 - 334
  • [23] Serum Ferritin and its Importance for SARS-CoV-2-Infected Patients
    Nasif, Wesam A.
    Mukhtar, Mohammed H.
    Althubiti, Mohammad A.
    Alamodi, Hiba S.
    Balkhir, Omar Y.
    Qurban, Yazeed K.
    Alhasni, Mohammad G.
    Alharbi, Ammar K.
    Alnemary, Sultan O.
    Fatani, Sameer H.
    CLINICAL LABORATORY, 2022, 68 (08) : 1543 - 1552
  • [24] Central nervous system complications in SARS-CoV-2-infected patients
    Zhonggui Li
    Danyu Lin
    Xiaoshuang Xu
    Xiaohuan Liu
    Jieli Zhang
    Kaixun Huang
    Feiyifan Wang
    Jianfeng Liu
    Zhi Zhang
    Enxiang Tao
    Journal of Neurology, 2023, 270 : 4617 - 4631
  • [25] Reduced Mortality With Ondansetron Use in SARS-CoV-2-Infected Inpatients
    Bayat, Vafa
    Ryono, Russell
    Phelps, Steven
    Geis, Eugene
    Sedghi, Farshid
    Etminani, Payam
    Holodniy, Mark
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
  • [26] Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects
    Griggs, Elizabeth
    Trageser, Kyle
    Naughton, Sean
    Yang, Eun-Jeong
    Mathew, Brian
    Van Hyfte, Grace
    Hellmers, Linh
    Jette, Nathalie
    Estill, Molly
    Shen, Li
    Fischer, Tracy
    Pasinetti, Giulio Maria
    ELIFE, 2023, 12
  • [27] Central nervous system complications in SARS-CoV-2-infected patients
    Li, Zhonggui
    Lin, Danyu
    Xu, Xiaoshuang
    Liu, Xiaohuan
    Zhang, Jieli
    Huang, Kaixun
    Wang, Feiyifan
    Liu, Jianfeng
    Zhang, Zhi
    Tao, Enxiang
    JOURNAL OF NEUROLOGY, 2023, 270 (10) : 4617 - 4631
  • [28] ZBP1 inflames the SARS-CoV-2-infected lung
    Yin, Chaoran
    Balachandran, Siddharth
    CELL RESEARCH, 2023, 33 (05) : 333 - 334
  • [29] Passive immunity in newborn from SARS-CoV-2-infected mother
    Cavaliere, Anna F.
    Marchi, Laura
    Aquilini, Donatella
    Brunelli, Tamara
    Vasarri, Pier L.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1810 - 1813
  • [30] Experience with sotrovimab treatment of SARS-CoV-2-infected patients in Denmark
    Rasmussen, Line Dahlerup
    Lebech, Anne-Mette
    Ovrehus, Anne
    Poulsen, Birgitte Klindt
    Christensen, Hanne Rolighed
    Nielsen, Henrik
    Johansen, Isik Somuncu
    Omland, Lars Haukali
    Wiese, Lothar
    Helleberg, Marie
    Storgaard, Merete
    Dalager-Pedersen, Michael
    Rasmussen, Thomas A.
    Benfield, Thomas
    Petersen, Tonny Studsgaard
    Andersen, Ase Bengard
    Gram, Mie Agermose
    Stegger, Marc
    Edslev, Sofie Marie
    Obel, Niels
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (06) : 1820 - 1833